Newsfeeds - Spark Newswire

2 minute read

Mid-Day Market Update: Dow Tumbles Over 300 Points; Acer Therapeutics Shares Jump

Today, 6:59 AM

Midway through trading Wednesday, the Dow traded down 0.92% to 33,997.95 while the NASDAQ fell 0.49% to 14,362.47. The S&P also fell, dropping 0.75% to 4,313.33.

ACER

2 minute read

26 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 6:59 AM

Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option agreement with Pfizer for capsids generated from Voyager's RNA-driven TRACER screening technology.

ACER

1 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 6:59 AM

ACER

5 minute read

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal

By Shanthi Rexaline

Today, 6:59 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

ABEO

1 minute read

Acer Therapeutics Stock Jumps As UCD Candidate Is Under FDA Review

By Vandana Singh

Today, 6:59 AM

The FDA has accepted for review Acer Therapeutics Inc (NASDAQ:ACER) and its partner, Relief Therapeutics Holding SA’s (OTC:RLFTF) marketing application for ACER-001 (sodium…

ACER

2 minute read

15 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

Today, 6:59 AM

Gainers

ACER

2 minute read

Acer Therapeutics and Relief Therapeutics Announced FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders With PDUFA Target Action Date of June 5, 2022

By Charles Gross

Today, 6:59 AM

Acer Therapeutics Inc. (Nasdaq: ACER) ("Acer") and its collaboration partner, RELIEF THERAPEUTICS Holding SA (OTC: RLFTF) ("Relief"), today announced that the U.S.

ACER

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 6:59 AM

ACER

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

Today, 6:59 AM

Gainers

ACER

1 minute read

Acer Therapeutics Q2 EPS $(0.23) Up From $(0.56) YoY

By Benzinga Newsdesk

Today, 6:59 AM

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.23) per share. This is a 58.93 percent increase over losses of $(0.56) per share from the same period last year.

ACER